steatotic liver disease - Search News

Order byBest matchMost fresh

News

GSK buys liver drug from Boston Pharmaceuticals

GSK to buy liver disease drug for up to $2 billion

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm Boston Pharmaceuticals, the British drugmaker said on Wednesday. Efimosfermin, a monthly subcutaneous injection,

Continue reading

· 1d · on MSN

Zacks Investment Research on MSN · 12h

GSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease Drug

GSK buys liver disease drug for up to $2 bn

European Medical Journal9h

Steatotic Liver Disease and Frailty in Older Adults

Discover a study that offers new insight into the link between frailty and steatotic liver disease in older adults.

12don MSN

Semaglutide found to have shocking benefit for liver disease patients in new study

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results